X. Paoletti

Designs of preoperative biomarkers trials in oncology: a systematic review of the literature.

I. Bièche, X. Paoletti, A. Stathis, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Patients’ perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study

X. Paoletti, C. Flahault, F. Bonnetain, 2017, European journal of cancer care.

Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French

Philippe Rougier, F. Bonnetain, Jean-Luc Raoul, 2008 .

Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials.

X Paoletti, X. Paoletti, M. Ezzalfani, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials.

P. Fumoleau, A. Floquet, C. Tourneau, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

X Paoletti, V. Servois, X. Paoletti, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.